Infinity Pharmaceuticals logo
Infinity Pharmaceuticals INFI
$ 0.04 -46.98%

Квартальный отчет 2023-Q2
добавлен 10.08.2023

report update icon

Infinity Pharmaceuticals Мультипликаторы 2011-2025 | INFI

Мультипликаторы по годам Infinity Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.4 -4.3 -4.9 -1.7 -6.1 -2.5 -3.3 -2.4 -43.1 -5.1 -19.6 -4.0

P/S

6.5 103.7 116.0 26.0 3.1 17.4 5.3 2.8 4.5 - 22.5 1.7

EPS

-0.5 -0.5 -0.7 -0.8 -0.2 -0.8 -0.6 -2.6 -0.4 -2.6 -1.7 -1.5

EV (Enterprise Value)

39.8 млн 175 млн 233 млн 98.2 млн 27.9 млн 81.2 млн 68.4 млн 307 млн 602 млн 614 млн 908 млн 245 млн

EBITDA per Share

-0.5 -0.52 -0.662 -0.798 -0.212 -0.687 -2.82 -2.54 -0.127 -2.63 -3.08 -1.37

EV/EBITDA

-3.4 -5.8 -1.9 -1.7 -2.2 -0.2 -0.9 -71.9 -4.8 -9.0 -4.8

PEG

-0.01 -0.23 0.27 -0.01 0.08 -0.07 0.04 -0.0 0.5 -0.09 -1.47 0.21

P/B

-0.9 8.9 -8.7 10.3 1.3 2.2 1.2 3.1 3.6 3.2 3.4 10.4

P/CF

-0.4 -4.7 -5.6 -1.8 -14.6 -2.8 -0.6 -3.4 6.4 -5.6 -13.0 -4.6

ROE %

232.90 -209.83 176.14 -609.07 -21.45 -87.64 -36.51 -130.26 -8.31 -62.99 -17.40 -259.45

ROA %

-105.26 -53.38 -102.98 -96.01 -18.69 -70.48 -23.96 -44.45 -4.72 -54.95 -16.08 -32.16

ROCE %

235.39 -209.00 -136.17 -116.15 -22.72 -76.31 -140.59 -58.10 -2.52 -61.23 -31.28 -40.34

Current Ratio

0.7 1.3 3.3 4.6 7.8 5.0 4.3 3.6 6.3 10.1 17.7 4.1

DSO

- - - - - - 1.7 4.0 1.4 - - 0.9

DIO

- - - - - - - - - - - -

DPO

- - 1049.6 81.0 6332.0 - - - - - - -

Операционный цикл

- - - - - - - - - - - -

Финансовый цикл

- - -1049.6 -81.0 -6332.0 - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
2022202220212021202020202019201920182018201720172016201620152015201420142013201320122012201120118000 8000 6000 6000 4000 4000 2000 2000 0 0 -2000 -2000
Download SVG
Download PNG
Download CSV

Все данные представлены в валюте USD

Мультипликаторы поквартально Infinity Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.11 -0.12 - -0.12 -0.13 -0.14 - -0.12 -0.13 -0.15 - -0.16 -0.16 -0.19 - -0.2 -0.18 -0.24 - 0.23 -0.12 -0.18 -0.14 -0.14 -0.34 -0.21 -0.46 -0.39 1.05 -0.82 -0.8 0.85 -0.78 -1.91 -0.83 2.08 -0.78 -0.87 -0.68 -0.71 -0.68 -0.57 -1.15 0.57 -0.54 -0.4 -0.53 -0.45 -0.44 -0.09

EBITDA per Share

- -0.13 - -0.12 -0.13 -0.14 - -0.12 -0.12 -0.15 - -0.14 -0.15 -0.18 - -0.18 -0.17 -0.24 - 0.23 -0.13 -0.18 -0.16 -0.12 -0.17 -0.19 -0.46 -0.35 1.1 -0.81 -0.8 0.91 -0.77 -1.89 -0.8 2.24 -0.71 -0.84 -0.69 -0.68 -0.67 -0.57 -1.15 0.62 -0.5 -0.36 -0.51 -0.37 -0.38 -0.05

ROE %

262.73 1318.86 1056.72 1023.39 891.51 -218.37 -82.80 -41.33 33.47 101.81 130.03 -17.74 -206.99 -384.28 -461.75 -436.24 -262.96 -140.15 -5.78 -21.07 -61.46 -83.71 -87.64 -100.16 -108.92 -9.14 -36.51 -48.46 18.35 -84.90 -130.26 -109.75 -103.64 -82.80 -8.31 -5.41 -71.55 -69.59 -62.99 -61.78 -38.98 -27.52 -17.40 -93.36 -176.69 -247.97 -259.46 -77.40 -76.01 -14.94

ROA %

-125.31 -97.80 -57.28 -68.61 -59.16 -50.76 -32.65 -56.90 -69.83 -82.93 -76.03 -99.32 -98.37 -95.72 -72.79 -50.56 -5.05 4.84 -5.04 -17.33 -51.52 -68.52 -70.48 -76.43 -79.98 -9.24 -23.96 -19.28 10.97 -44.51 -44.45 -41.81 -28.58 -25.57 -4.72 -8.06 -50.73 -54.56 -54.95 -54.68 -34.49 -24.73 -16.08 -13.37 -28.45 -33.51 -32.16 -9.60 -9.42 -1.85

ROCE %

267.81 1326.39 1061.41 1027.96 894.46 -218.26 -82.78 -44.31 27.61 93.49 122.95 -14.01 -189.44 -354.36 -441.48 -416.36 -254.29 -141.75 -6.62 -23.42 -64.98 -72.55 -76.36 -87.73 -95.47 -9.97 -37.46 -49.02 19.05 -84.44 -128.97 -107.90 -100.38 -78.04 -3.78 -1.55 -69.95 -69.40 -63.43 -62.19 -39.16 -27.49 -17.02 -90.03 -171.14 -240.18 -249.65 -75.05 -73.65 -12.75

Current Ratio

0.4 0.5 0.7 0.8 1.0 1.2 1.3 1.5 1.7 1.9 0.6 0.6 0.6 0.6 1.2 1.2 1.2 1.2 7.8 7.8 7.8 7.8 5.1 5.1 5.1 5.1 2.9 2.9 2.9 2.9 1.5 1.5 1.5 1.5 2.3 2.3 2.3 2.3 7.8 7.8 7.8 7.8 13.2 13.2 13.2 13.2 1.1 1.1 1.1 1.1

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Все данные представлены в валюте USD